EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors

Maria Gaia Mastrosimini, Erminia Manfrin, Andrea Remo, Mario De Bellis, Alice Parisi, Serena Pedron, Claudio Luchini, Matteo Brunelli, Serena Ammendola, Laura Bernardoni, Maria Cristina Conti Bellocchi, Armando Gabbrielli und 5 weitere

Pancreatology · 2023

DOI: 10.1016/j.pan.2023.05.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2023. Verfasst von Maria Gaia Mastrosimini und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Intellectual Disability, alpha-Thalassemia, Pancreatic Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/OBJECTIVES: Death domain-associated protein (DAXX) and/or α-thalassemia/mental retardation X-linked (ATRX) chromatin remodeling genes mutations and alternative lengthening of telomeres (ALT) activation are associated with more aggressive behavior of non-functional pancreatic neuroendocrine tumors (NF-PanNETs). We aimed to evaluate the reliability of such markers on endoscopic-ultrasound fine-needle biopsy (EUS-FNB) specimens. METHODS: Patients who underwent EUS-FNB and subsequent surgical resection for PanNETs between January 2017 and December 2019 were retrospectively identified. Immunohistochemistry (IHC) to evaluate DAXX/ATRX expression and fluorescence in situ hybridization (FISH) for ALT status were performed. Primary outcome was the concordance rate of markers expression between EUS-FNB and surgical specimens. Secondary aims were association between markers and lesion aggressiveness, their diagnostic performance in predicting aggressiveness, and agreement of preoperative and post-surgical Ki67-based grading. RESULTS: Forty-one NF-PanNETs (mean diameter 36.1 ± 26.5 mm) were included. Twenty-four showed features of lesion aggressiveness. Concordance of expressions of DAXX, ATRX, and ALT status between EUS-FNB and surgical specimens were 95.1% (κ = 0.828; p < 0.001), 92.7% (κ = 0.626; p < 0.001), and 100% (κ = 1; p < 0.001), respectively. DAXX/ATRX loss and ALT-positivity were significantly (p < 0.05) associated with metastatic lymphnodes and lymphovascular invasion. The combination of all tumor markers (DAXX/ATRX loss + ALT-positivity + grade 2) reached an accuracy of 73.2% (95%CI 57.1-85.8) in identifying aggressive lesions. Pre- and post-operative ki-67-based grading was concordant in 80.5% of cases (k = 0.573; p < 0.001). CONCLUSION: DAXX/ATRX expression and ALT status can be accurately evaluated in a preoperative setting on EUS-FNB samples, potentially improving the identification of patients with increased risk and poorer prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsIntellectual Disabilityalpha-ThalassemiaPancreatic NeoplasmsHumansX-linked Nuclear ProteinRetrospective StudiesBiopsy, Fine-NeedleIn Situ Hybridization, FluorescenceReproducibility of ResultsTelomereMolecular ChaperonesCo-Repressor Proteins

Stichwörter der Autor:innen

ALTFISHImmunohistochemistryPancreatic cancerPancreatic tumor

Substanzen

X-linked Nuclear ProteinATRX protein, humanDAXX protein, humanMolecular ChaperonesCo-Repressor Proteins

Autor:innen und Institutionen

  • Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.
  • Department of Pathology, ULSS9 "Scaligera", Verona, Italy.
  • Department of Surgery, Division of General and HPB Surgery, School of Medicine, University of Verona, Verona, Italy.
  • Digestive Endoscopy Unit, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.
  • Department of Medical and Surgical Sciences, Section of Gastroenterology, University of Foggia, Foggia, Italy.
  • General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.

Zitieren

APA

Mastrosimini, M. G., Manfrin, E., Remo, A., De Bellis, M., Parisi, A., Pedron, S., Luchini, C., Brunelli, M., Ammendola, S., Bernardoni, L., Conti Bellocchi, M. C., Gabbrielli, A., Facciorusso, A., Pea, A., Landoni, L., Scarpa, A., & Crinò, S. F. (2023). Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors. Pancreatology. https://doi.org/10.1016/j.pan.2023.05.002

Vancouver

Mastrosimini MG, Manfrin E, Remo A, De Bellis M, Parisi A, Pedron S, et al. Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors. Pancreatology. 2023. doi:10.1016/j.pan.2023.05.002

BibTeX
@article{Mastrosimini2023,
  author = {Mastrosimini, Maria Gaia and Manfrin, Erminia and Remo, Andrea and De Bellis, Mario and Parisi, Alice and Pedron, Serena and Luchini, Claudio and Brunelli, Matteo and Ammendola, Serena and Bernardoni, Laura and Conti Bellocchi, Maria Cristina and Gabbrielli, Armando and Facciorusso, Antonio and Pea, Antonio and Landoni, Luca and Scarpa, Aldo and Crinò, Stefano Francesco},
  title = {Endoscopic ultrasound fine-needle biopsy to assess DAXX/ATRX expression and alternative lengthening of telomeres status in non-functional pancreatic neuroendocrine tumors},
  journal = {Pancreatology},
  year = {2023},
  doi = {10.1016/j.pan.2023.05.002}
}
Kostenlos starten →